All
John Theurer's 10th Annual Life and Liberty Event Brings Cancer Survivors Together to Celebrate
September 19th 2018From an inaugural gathering in 2009 that attracted approximately 700 people, the Life and Liberty event has grown in size each year, with more than 4,000 patients in attendance at last September’s celebration. Organizers said about 6,000 were there this year.
Why is Cannabis for Cancer Unavailable for Most?
September 19th 2018Medical marijuana continues to receive mixed reviews in the world of health care, but for those affected by cancer, it offers a ray of hope. Celebrities like Olivia Newton-John confirm the benefits through their own personal use of the plant but many don't have access to it.
FDA Approves New Agent for Hairy Cell Leukemia
September 13th 2018The Food and Drug Administration (FDA) approved the use of Lumoxiti (moxetumomab pasudotox-tdfk) for patients with relapsed or refractory hairy cell leukemia (HCL) who previously had at least two prior systemic therapies, including treatment with a purine nucleoside analog.
FDA Grants Priority Review to Keytruda to Treat Non-Small Cell Lung Cancer Subgroup
September 12th 2018The Food and Drug Administration (FDA) granted priority review to Keytruda (pembrolizumab) monotherapy for the first-line treatment of patients with locally advanced or metastatic nonsquamous or squamous non-small cell lung cancer (NSCLC) whose tumors express PD-L1 without EGFR or ALK genomic tumor aberrations.
Doctor-Patient Discussions on Harms of Lung Cancer Screening 'Virtually Nonexistent'
September 8th 2018A small study showed that, despite national guideline recommendation, conversations between doctors and patients about the benefits and harms of lung cancer screening in those who are at high risk are not happening the way they should be.